Inhibitor Therapeutics, Inc. (INTI) Net income 2016–2025
Inhibitor Therapeutics, Inc. (INTI) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$3.3MFY2025 · since FY2016: -$7.0M → -$3.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.3M | +1.2% |
| FY2024 | -$3.3M | -10.3% |
| FY2023 | -$3.0M | -125.0% |
| FY2022 | $12.1M | +4153.9% |
| FY2021 | -$298,632 | +71.8% |
| FY2020 | -$1.1M | +61.3% |
| FY2019 | -$2.7M | +39.9% |
| FY2018 | -$4.6M | +10.8% |
| FY2017 | -$5.1M | +27.1% |
| FY2016 | -$7.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice